908 related articles for article (PubMed ID: 25129481)
1. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
Dai Z; Chen J; Chang Y; Christiano AM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
4. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.
Dai Z; Sezin T; Chang Y; Lee EY; Wang EHC; Christiano AM
Front Immunol; 2022; 13():955038. PubMed ID: 36203601
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting Janus kinases to treat alopecia areata.
Divito SJ; Kupper TS
Nat Med; 2014 Sep; 20(9):989-90. PubMed ID: 25198048
[TBL] [Abstract][Full Text] [Related]
6. The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells.
Kim JE; Lee YJ; Park HR; Lee DG; Jeong KH; Kang H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698510
[TBL] [Abstract][Full Text] [Related]
7. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.
Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J
J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121
[TBL] [Abstract][Full Text] [Related]
8. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
Lensing M; Jabbari A
Front Immunol; 2022; 13():955035. PubMed ID: 36110853
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3 Gallate Inhibits
Hamed FN; McDonagh AJG; Almaghrabi S; Bakri Y; Messenger AG; Tazi-Ahnini R
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30558329
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.
Dai Z; Xing L; Cerise J; Wang EH; Jabbari A; de Jong A; Petukhova L; Christiano AM; Clynes R
J Immunol; 2016 Aug; 197(4):1089-99. PubMed ID: 27412416
[TBL] [Abstract][Full Text] [Related]
11. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.
Mackay-Wiggan J; Jabbari A; Nguyen N; Cerise JE; Clark C; Ulerio G; Furniss M; Vaughan R; Christiano AM; Clynes R
JCI Insight; 2016 Sep; 1(15):e89790. PubMed ID: 27699253
[No Abstract] [Full Text] [Related]
12. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.
Jabbari A; Dai Z; Xing L; Cerise JE; Ramot Y; Berkun Y; Sanchez GA; Goldbach-Mansky R; Christiano AM; Clynes R; Zlotogorski A
EBioMedicine; 2015 Apr; 2(4):351-5. PubMed ID: 26137574
[TBL] [Abstract][Full Text] [Related]
13. Janus kinase inhibitors: An innovative treatment for alopecia areata.
Park H; Yu DA; Kwon O
J Dermatol; 2019 Aug; 46(8):724-730. PubMed ID: 31237712
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
15. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
Trüeb RM; Dias MFRG
Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
[TBL] [Abstract][Full Text] [Related]
16. Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway.
He X; Liu J; Gong Y; Lu W; Sha X; Cao C; Li Y; Wang J
J Ethnopharmacol; 2024 Sep; 331():118317. PubMed ID: 38723918
[TBL] [Abstract][Full Text] [Related]
17. Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice.
Lee E; Kim M; Lee YJ
Front Immunol; 2022; 13():874778. PubMed ID: 35799786
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease: Getting to the root of hair loss in alopecia.
Bray N
Nat Rev Drug Discov; 2014 Oct; 13(10):724-5. PubMed ID: 25233992
[No Abstract] [Full Text] [Related]
19. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.
de Jong A; Jabbari A; Dai Z; Xing L; Lee D; Li MM; Duvic M; Hordinsky M; Norris DA; Price V; Mackay-Wiggan J; Clynes R; Christiano AM
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282836
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
